ClinicalTrials.Veeva

Menu

Assessment of Clinical Effects of Coenzyme Q10 Levels in COVID-19 Patients in Intensive Care Unit

H

Hacettepe University

Status

Unknown

Conditions

COVID-19

Treatments

Diagnostic Test: blood sample

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The study will be done in Hacettepe University Anesthesiology and Reanimation Intensive Care Unit. The investigators will accept COVID-19 diagnosed or suspected patients to the ICU. In the first day of hospitalization and after that once a week, the investigators will take blood samples from the patients to evaluate Coenzyme q10 levels. Our hypothesis is that there is a relationship between low coenzyme q10 levels and poor clinical outcome.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Exclusion criteria

  • being under the age of 18
  • being pregnant
  • patient refusal

Trial design

150 participants in 2 patient groups

COVID-19 positive patients
Treatment:
Diagnostic Test: blood sample
COVID-19 negative patients
Treatment:
Diagnostic Test: blood sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems